AQST vs. NGD

Last updated Jun 13, 2026

AQST (Aquestive Therapeutics, Inc.) and NGD (New Gold Inc.) are both stocks. AQST operates in Drug Manufacturers - Specialty & Generic (Healthcare), while NGD operates in Gold (Basic Materials). At a 0.12 correlation, their price movements are largely independent.

Performance

AQST vs. NGD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Aquestive Therapeutics, Inc. (AQST) and New Gold Inc. (NGD). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

AQST

• 1D: -0.95%
• 1M: 0.97%
• YTD: -35.45%
• 6M: -32.85%
• 1Y: 25.98%
• 3Y*: 22.65%
• 5Y*: -0.29%
• 10Y*: —

NGD

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

AQST vs. NGD - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
AQST Aquestive Therapeutics, Inc.	-35.45%	81.46%	76.24%	123.92%	-76.81%	-27.29%	-8.08%	-7.62%	-58.14%
NGD New Gold Inc.	4.25%	251.21%	69.86%	48.98%	-34.67%	-31.51%	148.86%	16.28%	-57.00%

Correlation

The correlation between AQST and NGD is 0.00, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.00
Correlation (3Y) Calculated over the trailing 3-year period	0.14
Correlation (5Y) Calculated over the trailing 5-year period	0.14
Correlation (All Time) Calculated using the full available price history since Jul 25, 2018	0.12

The correlation between AQST and NGD shifts across timeframes, from 0.00 (1 year) to 0.14 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

EPS AQST : -$0.61 NGD : $1.61
PS Ratio AQST : 9.42 NGD : 3.30
Total Revenue (TTM) AQST : $50.27M NGD : $1.46B
Gross Profit (TTM) AQST : $20.92M NGD : $758.26M
EBITDA (TTM) AQST : -$53.08M NGD : $1.19B

Return for Risk

AQST vs. NGD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AQST

AQST Risk / Return Rank: 56
AQST Sharpe Ratio Rank: 54
AQST Sortino Ratio Rank: 59
AQST Omega Ratio Rank: 62
AQST Calmar Ratio Rank: 53
AQST Martin Ratio Rank: 52

NGD

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AQST vs. NGD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Aquestive Therapeutics, Inc. (AQST) and New Gold Inc. (NGD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	AQST	NGD	Difference
Sharpe ratio: Return per unit of total volatility	0.31	—	—
Sortino ratio: Return per unit of downside risk	1.11	—	—
Omega ratio: Gain probability vs. loss probability	1.16	—	—
Calmar ratio: Return relative to maximum drawdown	0.43	—	—
Martin ratio: Return relative to average drawdown	0.81	—	—

Drawdowns

Drawdown Indicators

	AQST	NGD	Difference
Max Drawdown Largest peak-to-trough decline	-96.68%	—	—
Max Drawdown (1Y) Largest decline over 1 year	-60.61%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-63.55%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-90.11%	—	—
Current Drawdown Current decline from peak	-78.01%	—	—
Average Drawdown Average peak-to-trough decline	-76.92%	—	—
Ulcer Index Depth and duration of drawdowns from previous peaks	32.01%	—	—

Volatility

Volatility by Period

	AQST	NGD	Difference
Volatility (1M) Calculated over the trailing 1-month period	21.51%	—	—
Volatility (6M) Calculated over the trailing 6-month period	68.41%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	85.07%	—	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	82.62%	—	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	87.69%	—	—

Dividends

AQST vs. NGD - Dividend Comparison

Neither AQST nor NGD has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both AQST and NGD in my portfolio?

AQST and NGD have a correlation of 0.00, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.